Oral Versus Intravenous Administration of Lysine: Equal Effectiveness in Reduction of Renal Uptake o...
Oral Versus Intravenous Administration of Lysine: Equal Effectiveness in Reduction of Renal Uptake of [111In-DTPA]Octreotide
About this item
Full title
Author / Creator
Publisher
United States: Soc Nuclear Med
Journal title
Language
English
Formats
Publication information
Publisher
United States: Soc Nuclear Med
Subjects
More information
Scope and Contents
Contents
During tumor therapy with radiolabeled somatostatin analogs, the kidneys are dose limiting. Renal uptake in patients can effectively be reduced by a 4- to 10-h intravenous infusion of a lysine/arginine solution, thereby increasing the maximum radiation dose to the tumor without renal side effects. Oral administration of amino acids could facilitate...
Alternative Titles
Full title
Oral Versus Intravenous Administration of Lysine: Equal Effectiveness in Reduction of Renal Uptake of [111In-DTPA]Octreotide
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68874439
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68874439
Other Identifiers
ISSN
0161-5505
E-ISSN
1535-5667
